- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Florida Cancer Specialists Researcher First-Authored SABCS Breast Cancer Study
A member of the clinical research team at Florida Cancer Specialists & Research Institute is to be a first author for a breast cancer study to be presented at San Antonio Breast Cancer Symposium.
Fort Myers, Florida — Medical oncologist Manish R. Patel, MD, a member of the clinical research team at Florida Cancer Specialists & Research Institute (FCS), served as the first author of a study examining dose escalation of an oral complete estrogen receptor antagonist/selective ER degrader in cases of advanced and/or metastatic estrogen receptor-positive, HER2-negative breast cancer.
Entitled, “Preliminary data from a phase I/II, multicenter, dose escalation study of OP-1250, an oral CERAN/SERD, in subjects with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer,” the study was shared at the San Antonio Breast Cancer Symposium held Dec. 7-12, 2021.
While still ongoing, the study’s analysis indicates an evolution in the standard of care, to include complete estrogen receptor antagonists.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
